Cargando…

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial

PURPOSE: The Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) trial established perioperative epirubicin, cisplatin, and fluorouracil chemotherapy as a standard of care for patients with resectable esophagogastric cancer. However, identification of patients at risk for relap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smyth, Elizabeth C., Fassan, Matteo, Cunningham, David, Allum, William H., Okines, Alicia F.C., Lampis, Andrea, Hahne, Jens C., Rugge, Massimo, Peckitt, Clare, Nankivell, Matthew, Langley, Ruth, Ghidini, Michele, Braconi, Chiara, Wotherspoon, Andrew, Grabsch, Heike I., Valeri, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2016
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019747/ https://www.ncbi.nlm.nih.gov/pubmed/27298411 http://dx.doi.org/10.1200/JCO.2015.65.7692

Ejemplares similares

Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy – results from the MRC OE02 oesophageal cancer trial
por: Davarzani, Nasser, et al.
Publicado: (2018)

A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial
por: Smyth, E C, et al.
Publicado: (2018)

Prognostic Significance of Negative Lymph Node Long Axis in Esophageal Cancer: Results From the Randomized Controlled UK MRC OE02 Trial
por: Kloft, Maximilian, et al.
Publicado: (2023)

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial
por: Sclafani, F., et al.
Publicado: (2015)

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial
por: Cunningham, David, et al.
Publicado: (2017)

Automated detection and delineation of lymph nodes in haematoxylin & eosin stained digitised slides
por: Beuque, Manon, et al.
Publicado: (2023)

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers
por: Smyth, Elizabeth C, et al.
Publicado: (2021)

Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer.
por: O'Byrne, K. J., et al.
Publicado: (1998)

Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients
por: Sclafani, Francesco, et al.
Publicado: (2016)

Characterisation of the immune-related transcriptome in resected biliary tract cancers
por: Ghidini, Michele, et al.
Publicado: (2017)

Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen.
por: Bonnefoi, H., et al.
Publicado: (1996)

Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro‐oesophageal junction
por: Allum, W. H., et al.
Publicado: (2019)

Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
por: Alderson, Derek, et al.
Publicado: (2017)

MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside
por: Ratti, Margherita, et al.
Publicado: (2020)

Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma: A Randomized Phase 2 Clinical Trial
por: Smyth, Elizabeth C., et al.
Publicado: (2019)

Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial
por: Hale, Matthew D., et al.
Publicado: (2016)

Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer
por: Ghidini, Michele, et al.
Publicado: (2020)

Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trials
por: Athauda, Avani, et al.
Publicado: (2023)

MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma
por: Trevisani, Francesco, et al.
Publicado: (2016)

Acute Cardiogenic Shock Induced by Infusional 5-Fluorouracil
por: Sulpher, Jeffrey, et al.
Publicado: (2014)

Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer.
por: Gabra, H., et al.
Publicado: (1996)

Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma
por: Silva, Arnaldo N. S., et al.
Publicado: (2022)

Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study
por: Cavallin, Francesco, et al.
Publicado: (2017)

Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study
por: Hewitt, L.C., et al.
Publicado: (2018)

Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma
por: Silva, Arnaldo N S, et al.
Publicado: (2022)

Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review)
por: Lampis, Andrea, et al.
Publicado: (2021)

Vault RNAs: hidden gems in RNA and protein regulation
por: Hahne, Jens Claus, et al.
Publicado: (2020)

Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
por: Fassan, Matteo, et al.
Publicado: (2018)

A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma
por: Starling, N, et al.
Publicado: (2009)

Genomic loss of heterozygosity and survival in the REAL3 trial
por: Smyth, Elizabeth C., et al.
Publicado: (2018)

Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
por: Fassan, Matteo, et al.
Publicado: (2019)

Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin
por: Gonzalez, M A, et al.
Publicado: (2003)

Successful infusional 5-fluorouracil administration in a patient with vasospastic angina
por: Tai, Shannon, et al.
Publicado: (2022)

Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches
por: Ratti, Margherita, et al.
Publicado: (2018)

Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study
por: Moorcraft, Sing Yu, et al.
Publicado: (2016)

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
por: Sclafani, Francesco, et al.
Publicado: (2018)

The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration: a randomized cross-over study.
por: Singer, J. M., et al.
Publicado: (1998)

Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas
por: Lynch, Ryan C., et al.
Publicado: (2022)

Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2016)

Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.
por: Bamias, A., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_47obtrhpc3s7ogg84s6skisrhi